MRNAModernaNeutralModerna
1w ago on
$MRNA $NVAX with red wave, is RFK a lame duck? https://t.co/gJwiCbVzuP
View original →
Opportunistic biotech trading bitch with a focus on nucleic acid-based and -targeted biotech. Fiercely independent. https://t.co/dfLqOuH7Uh
Cite asCryptoQuant has tracked the directional calls on MRNA by @RNAiAnalyst on X since Aug 2025: not yet scored on MRNA (as of Nov 11, 2026).
Other assets covered (14)
4 MRNA calls on record, a thin history.
Relative view by default: fewer than 30 MRNA calls or days on record.
Sentiment timeline shows relative sentiment within this analyst's history. A perma-bull showing 8 bullish : 2 bearish in a bear market sets that as their baseline. If you notice any errors, claim @RNAiAnalyst to submit corrections.
Hover the chart to read the thesis of that period · click a day to pin it
$MRNA $NVAX with red wave, is RFK a lame duck? https://t.co/gJwiCbVzuP
View original →$MRNA shorts celebrating that the mRNA cancer vaccine is unexciting. I have a feeling this is a bit premature and they may wake up tomorrow to a nightmare scenario. 0.42 and 0.5 are very meaningful HRs in a setting where most patient have not had a recurrence by 6 months.
View original →Covered and now trying to go long....because HR of 0.42 after 6 months. Now that would even impress @A_May_MD $MRNA https://t.co/1w4ffpQ2mi https://t.co/OEyG2KBm5K https://t.co/Oa8EBUYE13
View original →$mrna so $450 if results come in slightly worse than phase 2, $150 downside if HR 0.8 or less. Nicely framed by the ANALysts. Monday should be a volatile day for biotech. Extra points: which stocks are most exposed if specialist funds that are sig short $MRNA blow up on Monday?
View original →
